Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?

Bulletin of the World Health Organization - 1 Jan 2010

Clements C John, Coghlan Ben, Creati Mick, Locarnini Stephen, Tedder Richard S, Torresi Joseph

Abstract excerpt

Since its widespread introduction, the hepatitis B vaccine has become an essential part of infant immunization programmes globally. The vaccine has been particularly important for countries where the incidence of hepatitis B virus-related hepatocellular carcinoma is high. Effective treatment opti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Genome, Viral
Share to Global Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B Surface Antigens

Share to Hepatitis B Vaccines

Share to Hepatitis B virus

Share to Immunization Programs

Source

Open in PubMed Open full text

Identifiers

PMID: 20428355
DOI: 10.2471/BLT.08.065722
PMCID: PMC2802438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20428355-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?PMID 20428355Read ↗

Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention.Semantic proximity Read ↗

Molecular genesis of drug-resistant and vaccine-escape HBV mutants.Semantic proximity Read ↗

Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin.Semantic proximity Read ↗

Hepatitis B virus escape mutants induced by antiviral therapy.Semantic proximity Read ↗

Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.Semantic proximity Read ↗

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.Semantic proximity Read ↗

Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization.Semantic proximity Read ↗

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.Semantic proximity Read ↗

Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infantsSemantic proximity Read ↗

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical frameworkSemantic proximity Read ↗

Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.Semantic proximity Read ↗

Adaptation of the hepatitis B virus core protein to CD8+ T‐cell selection pressureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.